Clinical Trial Update: Melphalan in Patients With Neoplastic Meningitis [Phase 1]

View source ↗

Summary

Phase 1 trial of intrathecal melphalan in patients with neoplastic meningitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extragonadal Germ Cell Tumor
• Leptomeningeal Metastasis
• Leukemia
• Lymphoma
• Ovarian Cancer

Drugs mentioned

• Melphalan (Melphalan)

Snippet

Sponsor: Duke University | Conditions: Brain and Central Nervous System Tumors, Extragonadal Germ Cell Tumor | Phase 1 | Status: COMPLETED